(NASDAQ:OPK) Archives - Market Exclusive

Home Tags (NASDAQ:OPK)

Opko Health Inc. (NASDAQ:OPK) Insider Trading Activity – CEO Bought 200,000...

ME Staff - November 13, 2019

Opko Health Inc. (NASDAQ:OPK) Insider Trading Activity – CEO Bought 200,000...

ME Staff - October 30, 2019

OPKO Health, Inc. (NASDAQ:OPK) Files An 8-K Regulation FD Disclosure

ME Staff 8-k - July 29, 2019

OPKO Health, Inc. (NASDAQ:OPK) Files An 8-K Amendments to Articles of...

ME Staff 8-k - June 21, 2019

Opko Health Inc. (NASDAQ:OPK) Insider Trading Activity – CEO Bought 80,000...

ME Staff - April 23, 2019

Opko Health Inc. (NASDAQ:OPK) Insider Trading Activity – CEO Bought 50,000...

ME Staff - April 18, 2019

Opko Health Inc. (NASDAQ:OPK) Insider Trading Activity – CEO Bought 100,000...

ME Staff - March 28, 2019

Opko Health Inc. (NASDAQ:OPK) Insider Trading Activity – CEO Bought 40,000...

ME Staff - March 19, 2019

Opko Health Inc. (NASDAQ:OPK) Insider Trading Activity – CEO Bought 250,000...

ME Staff - March 15, 2019

Opko Health Inc. (NASDAQ:OPK) Insider Trading Activity – CEO Bought 50,000...

ME Staff - March 7, 2019

12 3...12 Page 1 of 12

/* */

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

September 25, 2023

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

September 18, 2023

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

September 11, 2023

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: (NASDAQ:OPK)

Opko Health Inc. (NASDAQ:OPK) Insider Trading Activity – CEO Bought 200,000...

Opko Health Inc. (NASDAQ:OPK) Insider Trading Activity – CEO Bought 200,000...

OPKO Health, Inc. (NASDAQ:OPK) Files An 8-K Regulation FD Disclosure

OPKO Health, Inc. (NASDAQ:OPK) Files An 8-K Amendments to Articles of...

Opko Health Inc. (NASDAQ:OPK) Insider Trading Activity – CEO Bought 80,000...

Opko Health Inc. (NASDAQ:OPK) Insider Trading Activity – CEO Bought 50,000...

Opko Health Inc. (NASDAQ:OPK) Insider Trading Activity – CEO Bought 100,000...

Opko Health Inc. (NASDAQ:OPK) Insider Trading Activity – CEO Bought 40,000...

Opko Health Inc. (NASDAQ:OPK) Insider Trading Activity – CEO Bought 250,000...

Opko Health Inc. (NASDAQ:OPK) Insider Trading Activity – CEO Bought 50,000...

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

POPULAR CATEGORY